CSLLY:OTCMKTS
CSL ADR
$30.92
arrow_downward
-2.55%(-0.81) 1D
Sep 18, 11:16:01 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSLLY...
Open
$31.08
High
$31.08
Low
$30.86
Mkt. cap
84.26B
Avg. vol.
126.75K
Volume
6.16K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.55
Shares outstanding
1.92B
No. of employees
29K
Open
$31.08
High
$31.08
Low
$30.86
Mkt. cap
84.26B
Avg. vol.
126.75K
Volume
6.16K
52-wk high
$36.28
52-wk low
$16.01
Beta
0.55
Shares outstanding
1.92B
No. of employees
29K
News stories
From web sources and news partners
Kalkine Media
·
5 hours ago
CSL Limited Repurchases 91,514 Shares on September 17 as Part of AUD$1.15 Billion On-Market Buy-Back
Kalkine Media
·
9 hours ago
CSL Shares (ASX:CSL) Surge: Is This ASX Healthcare Turnaround Real?
TipRanks
·
16 hours ago
CSL Continues Active On-Market Share Buy-Back Program
TheBull.com.au
·
16 hours ago
CSL Shares Move Positive On Year, A Bulls Eye Breakout
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com